EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Rosthornin B alleviates inflammatory diseases via directly targeting NLRP3

Yanqing Yang iD, Didi Liu iD, Hairuo Cao iD, Li Lu iD, Wei Zhang iD, Chenfei Liu iD, Yao Zeng iD, Feifei Shang iD, Ye Tao iD, Bao Zhao iD, Fengchao Wang iD, Tiantian Tang iD und 1 weitere

The FASEB Journal · 2024

DOI: 10.1096/fj.202401198r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Yanqing Yang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Inflammasomes, Mice, Inbred C57BL. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Anhui Province University Outstanding Youth Research Project, Natural Science Foundation of Anhui Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aberrant activation of the NLRP3 inflammasome contributes to the evolution of diverse inflammatory diseases. Inhibition of the NLRP3 inflammasome has been proven to be an effective treatment strategy for NLRP3‐driven diseases. This study revealed that multiple natural diterpenes from Isodon plants can inhibit the NLRP3 inflammasome, among which Rosthornin B (Ros B) exhibited the best inhibitory effect, with an IC 50 of 0.39 μM. Further study revealed that Ros B directly interacts with NLRP3, thereby restraining NEK7‐NLRP3 interaction and inhibiting NLRP3 inflammasome assembly and activation. Remarkably, Ros B had a significant therapeutic benefit in mouse models of NLRP3‐driven septic shock, peritonitis, and colitis. Our study has identified a series of natural diterpenes that target the NLRP3 inflammasome. These natural diterpenes, especially those with low IC 50 values, may lead to the development of new drugs and potential clinical therapies for diseases driven by NLRP3 inflammasome activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesMice, Inbred C57BLAnimalsMiceHumansNIMA-Related KinasesDiterpenesInflammationMaleColitisPeritonitisHEK293 Cells

Stichwörter der Autor:innen

NLRP3 inflammasomeNLRP3 inhibitorNLRP3‐driven diseasesRosthornin Bditerpenes

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesNlrp3 protein, mouseNIMA-Related KinasesDiterpenesNek7 protein, mouse

Autor:innen und Institutionen

  • Department of Clinical Laboratory, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China.
  • Anhui Provincial Key Laboratory of Immunology in Chronic Disease, Bengbu Medical University, Bengbu, Anhui, China.
  • Anhui Province Key Laboratory of Basic and Translational Research of Inflammation-Related Diseases, Bengbu, Anhui, China.
  • Department of Otolaryngology-Head and Neck Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Department of Otolaryngology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China.
  • Laboratory of Nutrition and Development, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.

ORCID-Profile: Yanqing Yang, Didi Liu, Hairuo Cao, Li Lu, Wei Zhang, Chenfei Liu, Yao Zeng, Feifei Shang, Ye Tao, Bao Zhao, Fengchao Wang, Tiantian Tang, Mengmeng Deng

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • Anhui Province University Outstanding Youth Research Project
  • Natural Science Foundation of Anhui Province
  • The First Affiliated Hospital of Bengbu Medical College Science Fund for Outstanding Young Scholars
  • The High-level Scientific and Technological Innovation Team of The First Affiliated Hospital of Bengbu Medical University
  • Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation)
  • Beijing Hospitals Authority
  • Anhui Provincial Department of Education Fund

Zitieren

APA

Yang, Y., Liu, D., Cao, H., Lu, L., Zhang, W., Liu, C., Zeng, Y., Shang, F., Tao, Y., Zhao, B., Wang, F., Tang, T., & Deng, M. (2024). Rosthornin B alleviates inflammatory diseases via directly targeting NLRP3. The FASEB Journal. https://doi.org/10.1096/fj.202401198r

Vancouver

Yang Y, Liu D, Cao H, Lu L, Zhang W, Liu C, et al. Rosthornin B alleviates inflammatory diseases via directly targeting NLRP3. The FASEB Journal. 2024. doi:10.1096/fj.202401198r

BibTeX
@article{Yang2024,
  author = {Yang, Yanqing and Liu, Didi and Cao, Hairuo and Lu, Li and Zhang, Wei and Liu, Chenfei and Zeng, Yao and Shang, Feifei and Tao, Ye and Zhao, Bao and Wang, Fengchao and Tang, Tiantian and Deng, Mengmeng},
  title = {Rosthornin B alleviates inflammatory diseases via directly targeting NLRP3},
  journal = {The FASEB Journal},
  year = {2024},
  doi = {10.1096/fj.202401198r}
}
Kostenlos starten →